Successful Treatment of Generalized Essential Telangiectasia With 6-Mercaptopurine.
<p>Generalized essential telangiectasia (GET) is a notoriously difficult to treat disorder with no current satisfactory treatments. This case and discussion report the use of 6-mercaptopurine (6-MP) as a successful treatment for GET. Moreover, we show that GET may represent a state of increased angiogenesis, a paradigm shift from the current understanding that these telangiectasias represent dilatations of only pre-existing vessels. This new view of GET may drive others to look at novel agents for treatment.</p> <p><em>J Drugs Dermatol. 2017;16(3):280-282.</em></p>.